Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | matrix metallopeptidase 13 (collagenase 3) | Starlite/ChEMBL | References |
Homo sapiens | matrix metallopeptidase 14 (membrane-inserted) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | matrix metallopeptidase 13 (collagenase 3) | 471 aa | 448 aa | 34.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | polyprenyl synthetase | 0.0408 | 1 | 1 |
Treponema pallidum | hexokinase (hxk) | 0.0158 | 0.2677 | 1 |
Brugia malayi | Polyprenyl synthetase family protein | 0.0103 | 0.1049 | 0.1049 |
Brugia malayi | Hexokinase family protein | 0.0099 | 0.0944 | 0.0944 |
Entamoeba histolytica | hexokinase 2 | 0.0158 | 0.2677 | 1 |
Schistosoma mansoni | hexokinase | 0.0158 | 0.2677 | 0.2677 |
Trypanosoma cruzi | hexokinase, putative | 0.0158 | 0.2677 | 0.1819 |
Onchocerca volvulus | 0.0158 | 0.2677 | 0.73 | |
Echinococcus multilocularis | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.0408 | 1 | 1 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Brugia malayi | geranylgeranyl pyrophosphate synthetase | 0.0103 | 0.1049 | 0.1049 |
Leishmania major | hexokinase, putative | 0.0158 | 0.2677 | 0.1819 |
Trypanosoma brucei | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Echinococcus granulosus | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.1972 | 0.1135 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0134 | 0.1972 | 0.1972 |
Brugia malayi | hypothetical protein | 0.0273 | 0.6031 | 0.6031 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.3763 | 0.3763 |
Echinococcus multilocularis | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Onchocerca volvulus | 0.0099 | 0.0944 | 0.2575 | |
Chlamydia trachomatis | geranylgeranyl pyrophosphate synthase | 0.0103 | 0.1049 | 0.5 |
Schistosoma mansoni | geranylgeranyl pyrophosphate synthase | 0.0103 | 0.1049 | 0.1049 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0408 | 1 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0158 | 0.2677 | 0.1819 |
Loa Loa (eye worm) | hypothetical protein | 0.0273 | 0.6031 | 0.5618 |
Loa Loa (eye worm) | geranylgeranyl pyrophosphate synthetase | 0.0103 | 0.1049 | 0.0115 |
Brugia malayi | Hexokinase family protein | 0.0158 | 0.2677 | 0.2677 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0408 | 1 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0273 | 0.6031 | 0.5567 |
Onchocerca volvulus | 0.0158 | 0.2677 | 0.73 | |
Onchocerca volvulus | 0.0158 | 0.2677 | 0.73 | |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0275 | 0.6109 | 0.5704 |
Toxoplasma gondii | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Loa Loa (eye worm) | matrixin family protein | 0.0201 | 0.3945 | 0.3314 |
Mycobacterium leprae | PROBABLE POLYPRENYL-DIPHOSPHATE SYNTHASE GRCC1 (POLYPRENYL PYROPHOSPHATE SYNTHETASE) | 0.0103 | 0.1049 | 0.5 |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.0408 | 1 | 1 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.0408 | 1 | 1 |
Echinococcus granulosus | hexokinase type 2 | 0.0158 | 0.2677 | 0.1819 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Leishmania major | farnesyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.0408 | 1 | 0.5 |
Echinococcus granulosus | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Brugia malayi | Muscleblind-like protein | 0.0172 | 0.3084 | 0.3084 |
Trypanosoma brucei | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Leishmania major | hexokinase, putative | 0.0158 | 0.2677 | 0.1819 |
Trypanosoma brucei | hexokinase, putative | 0.0158 | 0.2677 | 0.1819 |
Schistosoma mansoni | glutathione synthetase | 0.0103 | 0.1049 | 0.1049 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0275 | 0.6109 | 0.5704 |
Echinococcus granulosus | geminin | 0.0195 | 0.3763 | 0.3032 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0172 | 0.3084 | 0.2273 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.3763 | 0.3763 |
Plasmodium vivax | hexokinase, putative | 0.0158 | 0.2677 | 0.1819 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0259 | 0.564 | 0.5129 |
Echinococcus multilocularis | geminin | 0.0195 | 0.3763 | 0.3032 |
Loa Loa (eye worm) | hexokinase type II | 0.0158 | 0.2677 | 0.1913 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0259 | 0.564 | 0.5129 |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.0408 | 1 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0172 | 0.3084 | 0.2273 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0103 | 0.1049 | 0.5 |
Plasmodium falciparum | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Onchocerca volvulus | Matrilysin homolog | 0.0192 | 0.3667 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0158 | 0.2677 | 0.1913 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0103 | 0.1049 | 0.0115 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.3084 | 0.2362 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.1199 | 0.0281 |
Onchocerca volvulus | Hexokinase homolog | 0.0099 | 0.0944 | 0.2575 |
Loa Loa (eye worm) | matrixin family protein | 0.0105 | 0.1113 | 0.0186 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0273 | 0.6031 | 0.5567 |
Echinococcus multilocularis | hexokinase type 2 | 0.0158 | 0.2677 | 0.1819 |
Loa Loa (eye worm) | hexokinase | 0.0158 | 0.2677 | 0.1913 |
Echinococcus multilocularis | muscleblind protein | 0.0172 | 0.3084 | 0.2273 |
Schistosoma mansoni | trans-prenyltransferase | 0.0103 | 0.1049 | 0.1049 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.3084 | 0.2362 |
Entamoeba histolytica | hexokinase 1 | 0.0158 | 0.2677 | 1 |
Brugia malayi | Matrixin family protein | 0.0201 | 0.3945 | 0.3945 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0103 | 0.1049 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0275 | 0.6109 | 0.6109 |
Echinococcus granulosus | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Echinococcus multilocularis | hexokinase | 0.0158 | 0.2677 | 0.1819 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0408 | 1 | 1 |
Giardia lamblia | Farnesyl diphosphate synthase | 0.0408 | 1 | 0.5 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0105 | 0.1113 | 0.3035 |
Brugia malayi | hexokinase | 0.0158 | 0.2677 | 0.2677 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 140 nM | Inhibitory concentration against matrix metalloproteinase 13 | ChEMBL. | 15780611 |
IC50 (binding) | = 140 nM | Inhibitory concentration against matrix metalloproteinase 13 | ChEMBL. | 15780611 |
IC50 (binding) | = 8700 nM | Inhibitory concentration against matrix metalloproteinase 14 | ChEMBL. | 15780611 |
IC50 (binding) | = 8700 nM | Inhibitory concentration against matrix metalloproteinase 14 | ChEMBL. | 15780611 |
Ratio (binding) | = 62 | Ratio of matrix metalloproteinase 13 to matrix metalloproteinase 14 against the compound was determined | ChEMBL. | 15780611 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.